Stocks and Investing Stocks and Investing
Fri, January 17, 2020
[ 12:00 AM ] - United States, WOPRAI
Eric Sheridan Maintained (SPOT) at Strong Buy with Decreased Target to $180 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Brian Schwartz Downgraded (SPSC) to Hold on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Kenneth Herbert Maintained (SPR) at Hold with Decreased Target to $74 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Edward White Maintained (TGTX) at Strong Buy with Increased Target to $24 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Jonathan Petersen Downgraded (UDR) to Hold and Decreased Target to $50 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Frank McGann Upgraded (UGP) to Hold on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Edward Kelly Downgraded (UNFI) to Sell on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Ashwin Shirvaikar Maintained (WNS) at Strong Buy with Increased Target to $82 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Mayank Tandon Maintained (WNS) at Strong Buy with Increased Target to $87 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Katherine Fogertey Maintained (WING) at Strong Bu .. with Decreased Target to $135 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Andrew Strelzik Maintained (WING) at Buy with Decreased Target to $105 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Kyle White Initiated (WM) at Hold and Held Target at $123 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
John Glass Upgraded (YUM) to Buy and Increased Target to $118 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Anthony Pettinari Maintained (WY) at Strong Buy with Increased Target to $35 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Sophie Karp Maintained (XEL) at Buy with Decreased Target to $66 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Katy Huberty Downgraded (CDW) to Sell and Decreased Target to $124 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Walter Spracklin Maintained (CSX) at Hold with Increased Target to $25 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Allison Landry Maintained (CSX) at Buy with Increased Target to $28 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Michael Weinstein Downgraded (CMS) to Hold on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Bryan Bergin Initiated (TTEC) at Buy and Held Target at $50 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
David Nierengarten Downgraded (SYRS) to Hold and Held Target at $90 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Betsy Graseck Maintained (BK) at Sell with Decreased Target to $51 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Michael Carrier Reiterated (BK) at Hold with Decreased Target to $50 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Eric Sheridan Maintained (BKNG) at Hold on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Brian Schwartz Upgraded (BL) to Buy and Held Target at $75 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Kyle White Initiated (WCN) at Strong Buy and Held Target at $106 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Matt Bryson Upgraded (WDC) to Buy and Increased Target to $83 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Jonathan Petersen Upgraded (AVB) to Strong Buy and Increased Target to $248 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
Sophie Karp Maintained (AVA) at Sell with Increased Target to $42 on, Jan 17th, 2020
[ 12:00 AM ] - United States, WOPRAI
David Lebovitz Maintained (ASND) at Buy with Increased Target to $148 on, Jan 17th, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $148 on, Jan 17th, 2020


Published on 2024-10-26 20:20:34 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $140 to $148 on, Jan 17th, 2020.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019

Contributing Sources